Cipla Ltd has received approval from the U.S. Food and Drug Administration for granisetron hydrochloride tablets

The drug, a generic version of Roche Laboratories Inc's Kytril tablets, is indicated for prevention of nausea and vomiting caused by chemotherapy and radiation in the treatment of cancer.